Apogem Capital’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-412
Closed -$261K 155
2022
Q1
$261K Sell
412
-39
-9% -$20.1K 0.18% 137
2021
Q4
$304K Buy
451
+114
+34% +$69.4K 0.2% 138
2021
Q3
$221K Buy
+337
New +$288K 0.14% 168

Other funds holding AGL

Apogem Capital's AGL Position: Q2 2022 in Review

Apogem Capital sold out of Agilon Health (AGL) in Q2 2022, closing a stake of 412 shares — an estimated $261K sold.

Apogem Capital first reported a position in AGL in Q3 2021 and held it in 3 quarters. The position peaked at $304K in Q4 2021. 148 funds tracked by Wall St. Rank hold AGL as of Q2 2022.

  • Apogem Capital reported no remaining Agilon Health position as of Q2 2022 after selling out during the quarter.
  • Apogem Capital sold 412 Agilon Health shares in Q2 2022, an estimated $261K.
  • Apogem Capital first reported a position in Agilon Health in Q3 2021 and held it in 3 quarters.
  • Apogem Capital's Agilon Health position peaked at $304K in Q4 2021.
  • 148 funds tracked by Wall St. Rank held Agilon Health as of Q2 2022.

Based on Apogem Capital's 13F filing for Q2 2022, filed 15 Aug 2022.